Verlinde C L, Witmans C J, Pijning T, Kalk K H, Hol W G, Callens M, Opperdoes F R
BIOSON Research Institute, University of Groningen, The Netherlands.
Protein Sci. 1992 Dec;1(12):1578-84. doi: 10.1002/pro.5560011205.
The structure of triosephosphate isomerase from Trypanosoma brucei complexed with the competitive inhibitor N-hydroxy-4-phosphono-butanamide was determined by X-ray crystallography to a resolution of 2.84 A. Full occupancy binding of the inhibitor is observed only at one of the active sites of the homodimeric enzyme where the flexible loop is locked in a completely open conformation by crystal contacts. There is evidence that the inhibitor also binds to the second active site of the enzyme, but with low occupancy. The hydroxamyl group of the inhibitor forms hydrogen bonds to the side chains of Asn 11, Lys 13, and His 95, whereas each of its three methylene units is involved in nonpolar interactions with the side chain of the flexible loop residue Ile 172. Interactions between the hydroxamyl and the catalytic base Glu 167 are absent. The binding of this phosphonate inhibitor exhibits three unusual features: (1) the flexible loop is open, in contrast with the binding mode observed in eight other complexes between triosephosphate isomerase and various phosphate and phosphonate compounds; (2) compared with these complexes the present structure reveals a 1.5-A shift of the anion-binding site; (3) this is the first phosphonate inhibitor that is not forced by the enzyme into an eclipsed conformation about the P-CH2 bond. The results are discussed with respect to an ongoing drug design project aimed at the selective inhibition of glycolytic enzymes of T. brucei.
通过X射线晶体学确定了布氏锥虫磷酸丙糖异构酶与竞争性抑制剂N-羟基-4-膦酰基丁酰胺复合后的结构,分辨率为2.84埃。仅在同二聚体酶的一个活性位点观察到抑制剂的完全占据结合,其中柔性环通过晶体接触锁定在完全开放的构象中。有证据表明抑制剂也与酶的第二个活性位点结合,但占据率较低。抑制剂的异羟肟基团与Asn 11、Lys 13和His 95的侧链形成氢键,而其三个亚甲基单元中的每一个都与柔性环残基Ile 172的侧链参与非极性相互作用。异羟肟基团与催化碱Glu 167之间不存在相互作用。这种膦酸酯抑制剂的结合表现出三个不同寻常的特征:(1)柔性环是开放的,这与在磷酸丙糖异构酶与各种磷酸盐和膦酸酯化合物之间的其他八种复合物中观察到的结合模式相反;(2)与这些复合物相比,目前的结构显示阴离子结合位点有1.5埃的位移;(3)这是第一种未被酶强制形成围绕P-CH2键的重叠构象的膦酸酯抑制剂。针对一个旨在选择性抑制布氏锥虫糖酵解酶的正在进行的药物设计项目对结果进行了讨论。